NORCO 7.5325 MG FULL

The precise mechanism of the analgesic properties of acetaminophen is not established but is thought to involve central actions. However, specific CNS opioid receptors for endogenous compounds with opioid-like activity have been identified throughout the brain and spinal cord and are thought to play a role in the analgesic effects of this drug. The precise mechanism of the analgesic action is unknown. Clinically, dosage is titrated to provide adequate analgesia and may be limited by adverse reactions, including respiratory and CNS depression.

NORCO 7.5325 MG FULL

Like all full opioid agonists, there is no ceiling effect for analgesia with oxycodone. The principal therapeutic action of oxycodone is analgesia. Oxycodone is a full opioid agonist with relative selectivity for the mu-opioid receptor, although it can interact with other opioid receptors at higher doses. It may be represented by the following structural formula: The molecular formula for acetaminophen is C8H9NO2 and the molecular weight is 151.17.

Oxycodone and Acetaminophen Tablets, USP, contain acetaminophen, USP, 4’-hydroxyacetanilide, is a non-opiate, non-salicylate analgesic and antipyretic which occurs as a white, odorless, crystalline powder, possessing a slightly bitter taste. It is derived from the opium alkaloid, thebaine, and may be represented by the following structural formula: The molecular formula for oxycodone hydrochloride is C18H21NO4 Oxycodone and Acetaminophen Tablets, USP contain oxycodone, 14-hydroxydihydrocodeinone, a semisynthetic opioid analgesic which occurs as a white, odorless, crystalline powder having a saline, bitter taste. The tablets contain colloidal silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch and stearic acid. (*7.5 mg Oxycodone Hydrochloride, USP is equivalent to 6.7228 mg Oxycodone) Oxycodone and Acetaminophen is available in tablets for oral administration.Įach tablet for oral administration contains:

Norco 7.5325 mg